Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOPHOSPHAMIDE Cause Alopecia? 1,720 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 1,720 reports of Alopecia have been filed in association with CYCLOPHOSPHAMIDE (Cyclophosphamide). This represents 1.3% of all adverse event reports for CYCLOPHOSPHAMIDE.

1,720
Reports of Alopecia with CYCLOPHOSPHAMIDE
1.3%
of all CYCLOPHOSPHAMIDE reports
165
Deaths
226
Hospitalizations

How Dangerous Is Alopecia From CYCLOPHOSPHAMIDE?

Of the 1,720 reports, 165 (9.6%) resulted in death, 226 (13.1%) required hospitalization, and 39 (2.3%) were considered life-threatening.

Is Alopecia Listed in the Official Label?

Yes, Alopecia is listed as a known adverse reaction in the official FDA drug label for CYCLOPHOSPHAMIDE.

What Other Side Effects Does CYCLOPHOSPHAMIDE Cause?

Off label use (12,578) Febrile neutropenia (11,318) Drug ineffective (8,142) Neutropenia (7,352) Disease progression (7,100) Pyrexia (6,126) Product use in unapproved indication (5,750) Thrombocytopenia (4,669) Pneumonia (4,595) Nausea (4,561)

What Other Drugs Cause Alopecia?

DOCETAXEL (29,347) METHOTREXATE (14,360) ADALIMUMAB (13,726) ETANERCEPT (11,390) INFLIXIMAB (10,374) LEFLUNOMIDE (10,267) RITUXIMAB (10,119) ABATACEPT (10,043) TOCILIZUMAB (9,680) HYDROXYCHLOROQUINE (9,653)

Which CYCLOPHOSPHAMIDE Alternatives Have Lower Alopecia Risk?

CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOSERINE CYCLOPHOSPHAMIDE vs CYCLOSPORINE

Related Pages

CYCLOPHOSPHAMIDE Full Profile All Alopecia Reports All Drugs Causing Alopecia CYCLOPHOSPHAMIDE Demographics